Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L4WO
|
||||
Former ID |
DPR000186
|
||||
Drug Name |
SGN-19A
|
||||
Drug Type |
Antibody
|
||||
Indication | Hematologic malignancies [ICD9: 200-209; ICD10:C81-C86] | Preclinical | [551669] | ||
Company |
Seattle Genetics
|
||||
Target and Pathway | |||||
Target(s) | B-lymphocyte antigen CD19 | Target Info | [551669] | ||
NetPath Pathway | IL-7 Signaling Pathway | ||||
PANTHER Pathway | B cell activation | ||||
Pathway Interaction Database | BCR signaling pathway | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.